Aerie Pharma Balance Sheet - Annual (NASDAQ:AERI)

Add to My Stocks
$58.35 $2.15 (3.83%) AERI stock closing price Sep 20, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Aerie Pharma, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Aerie Pharma stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Aerie Pharma revenue Aerie Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Aerie Pharma balance sheet for 2017 shows cash on hand of $197.56M. The company has a debt to equity ratio of .

View latest 10 year balance sheet data to check Aerie Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Marketable Securities52.08M35.71M45.5M54.33M---
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets4.48M4.02M1.86M1.12M---
Total Current Assets
Property Plant & Equipment34.94M10.1M5.09M1.26M1.08M1.01M-
Accumulated Depreciation3M2.24M1.27M1.02M---
Net Property Plant & Equipment
Investment & Advances--13.8M18.27M---
Other Non-Current Assets-------
Deferred Charges-------
Deposits & Other Assets4.2M2.7M3.07M1.52M---
Total Assets
Notes Payable-----2.33M-
Accounts Payable6.24M18.82M16.56M8.33M3.48M1.43M2.7M
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses18.93M------
Income Taxes Payable-------
Other Current Liabilities-------
Total Current Liabilities
Deferred Taxes/Income-------
Convertible Debt123.84M123.53M123.23M124.15M---
Long-Term Debt-------
Non-Current Capital Leases-------
Other Long-Term Liabilities5.64M----2.45M1.09M
Total Liabilities
Minority Interest-------
Preferred Stock-----60.89M60.34M
Common Stock Net-------
Capital Surplus597.31M422M236.49M171.32M162.02M--
Retained Earnings-461.72M-316.62M-217.56M-143.2M-95.06M-63.92M-48.81M
Treasury Stock-------
Other Liabilities-0.02M-0.06M-0.17M-0.1M---
Shareholders Equity135.59M105.34M18.77M28.04M66.97M-3.02M11.65M
Total Liabilities & Shareholders Equity290.27M248.25M159.12M161.08M70.45M3.21M15.45M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Aerie Pharma stock price, and Aerie Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Aerie Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Aerie Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for AERI stock as of 2017 is $290.27M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Aerie Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for AERI stock stand at $154.67M.

Aerie Pharma Balance Sheet - Key Ratios